Advertisement

Topics

Gritstone Oncology, Inc. Company Profile

01:53 EST 13th November 2018 | BioPortfolio

Gritstone is a privately-held company developing personalized cancer immunotherapies to fight multiple cancer types. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunology, and immunotherapy design. The Company’s goal is to extend the benefits of immunotherapy by leveraging new insights into the immune system’s ability to destroy cancer cells, based on the study of patients treated with checkpoint inhibitors such as PD-(L)1 monoclonal antibodies. Gritstone’s approach seeks to generate a therapeutic immune response in these patients by unleashing the demonstrated natural power of a patient’s own immune system to recognize tumor-specific neoantigens, or TSNA, in order to destroy tumor cells. The importance of TSNA as targets for the immune system was first recognized in 2014 and 2015 by two of our co-founders, Dr. Timothy Chan and Dr. Naiyer Rizvi. Leveraging these insights, Gritstone has built a personalized immunotherapy approach on two key pillars—first, through its proprietary Gritstone EDGE™ artificial intelligence-based platform, conferring a powerful ability to predict, from a routine tumor biopsy, the TSNA that are presented on a patient’s tumor cells; and second, Gritstone’s ability to develop and manufacture a potent immunotherapy utilizing a patient’s unique TSNA to drive the patient’s immune system to attack and destroy tumors. Gritstone is headquartered in the San Francisco Bay Area with key functions located in Cambridge, MA and Pleasanton, CA. The company launched in August 2015 and has received funding from leading blue-chip biotechnology investors, including Versant Ventures, The Column Group, Clarus, Frazier Healthcare Partners, Lilly Asia Ventures, GV, Redmile Group and Casdin Capital. More information can be found at www.gritstone.com or @gritstoneonc.


News Articles [482 Associated News Articles listed on BioPortfolio]

bluebird bio and Gritstone Oncology to Collaborate

bluebird bio (NASDAQ:BLUE) and Gritstone Oncology announced Thursday (August 23) in a joint press release the two will research, develop and commercialize oncology cell therapy treatments. The post bl...

Bluebird Bio and Gritstone Oncology partner on cancer cell therapies

US-based biotechnology companies Bluebird Bio and Gritstone Oncology have entered into strategic collaboration for the development of new cancer cell...Read More... The post Bluebird Bio and Gritstone...

Gritstone gets $10mm through Series C ahead of IPO

Gritstone Oncology Inc. (cancer immunotherapies) received $10mm through an investment in its Series C preferred shares from new partner bluebird bio. The companies penned a deal potentially worth up t...

Gritstone gets $21mm through Series C ahead of IPO

Gritstone Oncology Inc. (cancer immunotherapies) raised $21mm through its Series C round, including a $10mm investment from new partner bluebird bio. The companies penned a deal potentially worth up t...

bluebird bio and Gritstone Oncology Collaborate to Develop Novel Cancer Cell Therapies

CAMBRIDGE, Mass. & EMERYVILLE, Calif.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commer...

Gritstone Oncology Receives Notice of Allowance from U.S. ...

Gritstone to be Issued Patent for its EDGE™ Deep Learning Model to Identify Neoantigens for Inclusion in Personalized Cancer Immunotherapies Read more...

Upsized IPO brings in $100M for Gritstone

An upsized initial public offering pulled in $100 million for Gritstone Oncology.  -More- 

BMS and Gritstone enter solid tumor trial collaboration

Bristol-Myers Squibb Co. and Gritstone Oncology will together evaluate immunotherapy combinations for advanced solid tumors.

PubMed Articles [1250 Associated PubMed Articles listed on BioPortfolio]

Burnout and Resiliency in Canadian Oncology Residents: a Nationwide Resident and Program Director Survey.

To measure burnout rates and resiliency scores in Canadian Oncology residents and to advance the knowledge regarding resiliency and wellness training in Canadian Oncology residency programs.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

Integrative Oncology Scholars Program: A Model for Integrative Oncology Education.

Oncology providers are often confronted by patients who use complementary or alternative therapies, but have limited knowledge or confidence on how to advise patients on appropriate use. Despite this,...

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey.

Searching for Oncology-Related Information.

To provide an overview of the literature review process and current information resources relevant to oncology nursing topics.

Clinical Trials [547 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Integrative Care Training Program for Nurses on Supportive Cancer Care

The integration of complementary medicine in supportive and palliative cancer care (i.e., Integrative Oncology) is becoming more prevalent in many of the leading oncology centers in Israel...

Companies [742 Associated Companies listed on BioPortfolio]

Gritstone Oncology

Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together distinguished scientific founders, an experienced and ...

Gritstone Oncology, Inc.

Gritstone is a privately-held company developing personalized cancer immunotherapies to fight multiple cancer types. Gritstone brings together distinguished scientific founders, a...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

OncLive

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary O...

Cold Spring Publishing, LLC

Cold Spring Publishing, LLC, (CSP) is a medical publishing company whose principals have more than 50 years of combined publishing experience, with a specific focus in oncology. CSP publishes JNCCN --...

More Information about "Gritstone Oncology, Inc." on BioPortfolio

We have published hundreds of Gritstone Oncology, Inc. news stories on BioPortfolio along with dozens of Gritstone Oncology, Inc. Clinical Trials and PubMed Articles about Gritstone Oncology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gritstone Oncology, Inc. Companies in our database. You can also find out about relevant Gritstone Oncology, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...


Corporate Database Quicklinks



Searches Linking to this Company Record